Compositions for treating joint or connective tissue disease comprising dextran or poloxamer
AssigneeMedicine Park Co., Ltd
InventorsYoo Sin Park, Il Hoon Lee
Life of this patent
Estimating the term…
Abstract
Disclosed is a composition for treating a joint disease or a connective tissue disease, a composition for cartilage regeneration, or a composition for treating an inflammatory disease, each of the compositions containing dextran, poloxamer or a mixture thereof. The composition stays in the joint or connective tissue for a long time due to the shock-absorbing effect, coating effect or anti-inflammation effect, relieves the shock, covers a damaged portion in a specific manner thereto, or reduces inflammation of an adhered portion. Thus, the composition may be useful for the treatment of the joint disease, the connective tissue disease, or for the cartilage regeneration.
Claims20
A method of treating a degenerative disease of joints or connective tissue diseases, the method comprising:
- administering to a subject in need thereof a composition comprising a mixture of dextran having an average molecular weight in a range of about 800 Da to about 1,200 Da and poloxamer.
A method of regenerating or protecting of a cartilage, the method comprising:
- administering to a subject in need thereof a composition comprising a mixture of dextran having an average molecular weight in a range of about 800 Da to about 1,200 Da and poloxamer.
A method of treating inflammatory diseases, the method comprising:
- administering to a subject in need thereof a composition comprising a mixture of dextran having an average molecular weight in a range of 800 Da to 1,200 Da and poloxamer.
Dependencies are inferred from the claim text.